Mass proliferation culture method of nk cells
AssigneeHanbio Co., Ltd.
InventorsDa Witt KANG, Hyun Chul KANG
Life of this patent
Estimating the term…
Loading patent…
AssigneeHanbio Co., Ltd.
InventorsDa Witt KANG, Hyun Chul KANG
Estimating the term…
The present invention relates to a culture method of NK cell, the method comprising: 1) isolating a pellet of peripheral blood mononuclear cell (PBMC) containing immune cells from blood by using ficoll and centrifugation; 2) culturing the isolated PBMC in an anti-CD16 antibody-coated incubator in a medium containing RPMI culture medium, plasma, IL-2, IL-15, anti-CD56, anti-NKp46, and anti-NKp30; 3) subculturing the cultured PBMC in RPMI medium, albumin, IL-2, IL-15, anti-CD56, anti-NKp46, and anti-NKp30; and 4) treating the subcultured PBMC in a medium composition based on RPMI to which anti-NKp30, anti-NKp46 and anti-CD56 antibodies are added with a cytokine selected from a cytokine group consisting of IL-2, IL-15, and IL-2+IL-15 to activate NK cells. The present invention is an optimal combination that can effectively activate cells when NK cells are treated with IL-2 and IL-15 among various cytokines, and when treated with IL-2+IL-15, mass culture of NK cells is possible. Since apoptosis or killing ability of cancer cells can be promoted when this is used, the present invention can be used as an effective immune cell therapy for preventing or treating cancer.
A culture method of NK cell, the method comprising:
Dependencies are inferred from the claim text.